168 related articles for article (PubMed ID: 24787708)
1. Oncogenic functions of the cancer-testis antigen SSX on the proliferation, survival, and signaling pathways of cancer cells.
D'Arcy P; Maruwge W; Wolahan B; Ma L; Brodin B
PLoS One; 2014; 9(4):e95136. PubMed ID: 24787708
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneous expression of the SSX cancer/testis antigens in human melanoma lesions and cell lines.
dos Santos NR; Torensma R; de Vries TJ; Schreurs MW; de Bruijn DR; Kater-Baats E; Ruiter DJ; Adema GJ; van Muijen GN; van Kessel AG
Cancer Res; 2000 Mar; 60(6):1654-62. PubMed ID: 10749136
[TBL] [Abstract][Full Text] [Related]
3. Cancer/testis antigen expression in human mesenchymal stem cells: down-regulation of SSX impairs cell migration and matrix metalloproteinase 2 expression.
Cronwright G; Le Blanc K; Götherström C; Darcy P; Ehnman M; Brodin B
Cancer Res; 2005 Mar; 65(6):2207-15. PubMed ID: 15781633
[TBL] [Abstract][Full Text] [Related]
4. Expression and immunotherapeutic targeting of the SSX family of cancer-testis antigens in prostate cancer.
Smith HA; Cronk RJ; Lang JM; McNeel DG
Cancer Res; 2011 Nov; 71(21):6785-95. PubMed ID: 21880588
[TBL] [Abstract][Full Text] [Related]
5. Expression of synovial sarcoma X (SSX) antigens in epithelial ovarian cancer and identification of SSX-4 epitopes recognized by CD4+ T cells.
Valmori D; Qian F; Ayyoub M; Renner C; Merlo A; Gnjatic S; Stockert E; Driscoll D; Lele S; Old LJ; Odunsi K
Clin Cancer Res; 2006 Jan; 12(2):398-404. PubMed ID: 16428478
[TBL] [Abstract][Full Text] [Related]
6. CD4+ T cell responses to SSX-4 in melanoma patients.
Ayyoub M; Merlo A; Hesdorffer CS; Rimoldi D; Speiser D; Cerottini JC; Chen YT; Old LJ; Stevanovic S; Valmori D
J Immunol; 2005 Apr; 174(8):5092-9. PubMed ID: 15814740
[TBL] [Abstract][Full Text] [Related]
7. The effect of SYT-SSX and extracellular signal-regulated kinase (ERK) on cell proliferation in synovial sarcoma.
Cai W; Sun Y; Wang W; Han C; Ouchida M; Xia W; Zhao X; Sun B
Pathol Oncol Res; 2011 Jun; 17(2):357-67. PubMed ID: 21234732
[TBL] [Abstract][Full Text] [Related]
8. Proteasome-assisted identification of a SSX-2-derived epitope recognized by tumor-reactive CTL infiltrating metastatic melanoma.
Ayyoub M; Stevanovic S; Sahin U; Guillaume P; Servis C; Rimoldi D; Valmori D; Romero P; Cerottini JC; Rammensee HG; Pfreundschuh M; Speiser D; Lévy F
J Immunol; 2002 Feb; 168(4):1717-22. PubMed ID: 11823502
[TBL] [Abstract][Full Text] [Related]
9. Vaccines targeting the cancer-testis antigen SSX-2 elicit HLA-A2 epitope-specific cytolytic T cells.
Smith HA; McNeel DG
J Immunother; 2011 Oct; 34(8):569-80. PubMed ID: 21904219
[TBL] [Abstract][Full Text] [Related]
10. Identification of a common HLA-A*0201-restricted epitope among SSX family members by mimicking altered peptide ligands strategy.
He Y; Mao L; Lin Z; Deng Y; Tang Y; Jiang M; Li W; Jia Z; Wang J; Ni B; Wu Y
Mol Immunol; 2008 May; 45(9):2455-64. PubMed ID: 18295890
[TBL] [Abstract][Full Text] [Related]
11. Inducible expression of a prostate cancer-testis antigen, SSX-2, following treatment with a DNA methylation inhibitor.
Dubovsky JA; McNeel DG
Prostate; 2007 Dec; 67(16):1781-90. PubMed ID: 17929270
[TBL] [Abstract][Full Text] [Related]
12. SS18-SSX fusion protein-induced Wnt/β-catenin signaling is a therapeutic target in synovial sarcoma.
Trautmann M; Sievers E; Aretz S; Kindler D; Michels S; Friedrichs N; Renner M; Kirfel J; Steiner S; Huss S; Koch A; Penzel R; Larsson O; Kawai A; Tanaka S; Sonobe H; Waha A; Schirmacher P; Mechtersheimer G; Wardelmann E; Büttner R; Hartmann W
Oncogene; 2014 Oct; 33(42):5006-16. PubMed ID: 24166495
[TBL] [Abstract][Full Text] [Related]
13. Expression of SSX genes in human tumors.
Türeci O; Chen YT; Sahin U; Güre AO; Zwick C; Villena C; Tsang S; Seitz G; Old LJ; Pfreundschuh M
Int J Cancer; 1998 Jul; 77(1):19-23. PubMed ID: 9639388
[TBL] [Abstract][Full Text] [Related]
14. SSX expression in gynecological cancers and antibody response in patients.
Hasegawa K; Koizumi F; Noguchi Y; Hongo A; Mizutani Y; Kodama J; Hiramatsu Y; Nakayama E
Cancer Immun; 2004 Dec; 4():16. PubMed ID: 15603546
[TBL] [Abstract][Full Text] [Related]
15. Loss of G3BP1 suppresses proliferation, migration, and invasion of esophageal cancer cells via Wnt/β-catenin and PI3K/AKT signaling pathways.
Zhang LN; Zhao L; Yan XL; Huang YH
J Cell Physiol; 2019 Nov; 234(11):20469-20484. PubMed ID: 30989663
[TBL] [Abstract][Full Text] [Related]
16. Tumor-reactive, SSX-2-specific CD8+ T cells are selectively expanded during immune responses to antigen-expressing tumors in melanoma patients.
Ayyoub M; Rimoldi D; Guillaume P; Romero P; Cerottini JC; Valmori D; Speiser D
Cancer Res; 2003 Sep; 63(17):5601-6. PubMed ID: 14500401
[TBL] [Abstract][Full Text] [Related]
17. The SSX family of cancer-testis antigens as target proteins for tumor therapy.
Smith HA; McNeel DG
Clin Dev Immunol; 2010; 2010():150591. PubMed ID: 20981248
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of mouse SSX genes: a multigene family on the X chromosome with restricted cancer/testis expression.
Chen YT; Alpen B; Ono T; Gure AO; Scanlan MA; Biggs WH; Arden K; Nakayama E; Old LJ
Genomics; 2003 Dec; 82(6):628-36. PubMed ID: 14611804
[TBL] [Abstract][Full Text] [Related]
19. The inhibition of cell proliferation using silencing of N-cadherin gene by siRNA process in human melanoma cell lines.
Ciołczyk-Wierzbicka D; Gil D; Laidler P
Curr Med Chem; 2012; 19(1):145-51. PubMed ID: 22300088
[TBL] [Abstract][Full Text] [Related]
20. Physiological β-catenin signaling controls self-renewal networks and generation of stem-like cells from nasopharyngeal carcinoma.
Cheng Y; Cheung AK; Ko JM; Phoon YP; Chiu PM; Lo PH; Waterman ML; Lung ML
BMC Cell Biol; 2013 Sep; 14():44. PubMed ID: 24073846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
